Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
IRCCS San Raffaele
Canadian Cancer Trials Group
University of Washington
Children's Oncology Group
University of Washington
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Duke University
National Cancer Institute (NCI)
Bio-Path Holdings, Inc.
Poitiers University Hospital
St. Jude Children's Research Hospital
Pfizer
Aileron Therapeutics, Inc.
University of Maryland, Baltimore
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Heidelberg University
University of Washington
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Hospital Israelita Albert Einstein
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Children's Oncology Group
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Baylor Research Institute
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Children's Oncology Group